Quotation in Aptinyx will resume at 4:30pm E.T., acc Shares have been halted ahead of the company’s announcement that its Phase 2 Study of NYX-458 did not demonstrate sufficient efficacy in patients with cognitive impairment associated with Parkinson’s disease and dementia with Lewy bodies.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on APTX: